Clasado Biosciences, a global leader in the innovative development of clinically proven prebiotic ingredient and product solutions, will attend 2019’s Probiota Americas as part of a drive to boost the company’s presence in North America.
Clasado is undergoing a significant transformation, following the appointment of Per Rehné as Chief Executive Officer, to develop into an innovation led commercially-driven company. Its presence at Probiota Americas is particularly important as the demand for prebiotics in the region is expected to witness a 9.7% CAGR from 2016 to 2024.
Per Rehné commented: “Probiota Americas is a premier event and has become increasingly important for companies operating in the microbiome space. It’s especially exciting for Clasado as the event has expanded its focus from probiotics and is now covering prebiotics to a large extent.
“This is extremely important for our commercialised prebiotic GOS Bimuno as we look to gain further exposure in the North American market. We are looking forward to the incredible networking opportunity that Probiota Americas offers, as well as connecting with new business partners, customers and scientific thought leaders.”
Organised by Nutraingredients USA, Probiota Americas is the leading annual event for the prebiotic, probiotic and the microbiota focused food and pharmaceutical industries. This year’s event will be held 24-26 June, at the JW Marriott Parq, Vancouver, Canada.
Clasado is a leading biotechnology pioneer in the development of microbiome science producing prebiotic ingredients and consumer products aimed at gastrointestinal wellness destined for the food and healthcare sectors.
To find out more about Clasado Biosciences, please visit www.clasado.com
